Gilead (GILD) calls active into late stage NASH study fails
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $125.05 +0.14%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -462.7%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: -462.7%
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) February call option implied volatility is at 25, March is at 26, compared to its 52-week range of 19 to 43 into late stage NASH study fails. Call put ratio 4 calls to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Gilead's Trodelvy for first-line metastatic TNBC
- FedEx (FDX) call put ratio 1 call to 2.8 puts with a focus on June 26 weekly 325 puts into quarter results
- Tenable Holdings, Inc. (TENB) call put ratio 80 calls to 1 put with a focus on 200 contracts of July 32 calls as share price up 5.6%
Create E-mail Alert Related Categories
OptionsRelated Entities
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
